Latest News

In early March 2026, Maple Leaf Foods reported strong 2025 results, including 8.1% fourth-quarter revenue growth, higher adjusted EBITDA, completion of its pork spin-off, and guidance for mid-single-digit revenue growth and margin expansion in 2026. The Board also approved about 10% dividend growth for 2026, lifting the quarterly payout from CA$0.19 to CA$0.21 per share and reinforcing its focus on shareholder returns. Now we will examine how this combination of solid earnings momentum and...

Okta (OKTA) just paired a strong fourth quarter with a more cautious outlook, as record contract value and AI driven identity products met softer guidance and a fresh US$763.4m shelf registration for employee stock offerings. See our latest analysis for Okta. Okta’s 11.3% 7 day share price return and 1.3% 1 day gain suggest a positive short term reaction to earnings and AI identity news. However, the 1 year total shareholder return of 28.2% and 5 year total shareholder return of 64.4%...

AutoZone, Inc. reported past second-quarter 2026 results showing sales rising to US$4,274.10 million from US$3,952.01 million a year earlier, while net income eased to US$468.86 million and diluted EPS from continuing operations slipped to US$27.63. Alongside these mixed results, AutoZone continued its long-running capital return program, repurchasing 85,000 shares for US$310.80 million and bringing total buybacks since 2008 to about US$32.36 billion. Next, we'll examine how rising sales but...

Oscar Health recently presented at the 47th Annual Raymond James Institutional Investor Conference in Orlando, where its CFO reiterated the 2026 outlook and addressed policy and capital concerns. Management also highlighted stronger-than-expected enrollment of 3.4 million members and extensive reinsurance support, underscoring how scale and risk-sharing underpin the business model. Next, we’ll explore how this reaffirmed outlook and higher enrollment may influence Oscar Health’s investment...

In February 2026, Capital Southwest Corporation’s board declared past monthly regular dividends of US$0.1934 per share for April, May, and June 2026, with corresponding ex-dividend, record, and payment dates for each month. The company also announced a supplemental dividend of US$0.06 per share for the June 2026 quarter, underscoring its emphasis on shareholder cash returns alongside regular distributions. With the newly declared regular and supplemental dividends highlighting cash returns,...

Elevated pre market trading in Hutchison Port Holdings Trust (SGX:NS8U) ahead of its 28 July 2026 earnings has put the Singapore based port operator in focus as investors weigh sector headwinds and distribution risks. See our latest analysis for Hutchison Port Holdings Trust. At a last close of $0.20, Hutchison Port Holdings Trust has seen a 2.04% 1 day share price return. However, a 7 day share price return of 11.11% and a 30 day share price return of 9.09% point to fading short term...

SGS collaboration with Exterra puts sustainable mining in focus SGS (SWX:SGSN) has entered a long-term collaboration with Exterra Technologies to test on-site regeneration of chemical inputs in mineral production, aiming to cut reagent costs and reduce environmental impact. See our latest analysis for SGS. While SGS shares have eased in the short term, with a 7 day share price return of 4.02% decline and a 30 day share price return of 2.37% decline, the 1 year total shareholder return of...

AnaptysBio (ANAB) has drawn fresh attention after reporting a fourth quarter earnings swing to net income of US$49.61 million, supported by collaboration revenues and milestone payments tied to cancer drug Jemperli. See our latest analysis for AnaptysBio. The strong earnings swing and Jemperli related revenues arrive after a sharp rerating in the shares. The current US$55.41 price follows a 24.49% 90 day share price return and a 1 year total shareholder return of 239.11%, suggesting momentum...

In February 2026, Paychex announced new AI-driven enhancements across its Paycor and Paychex Flex platforms, including automated scheduling, time and attendance, and time-off management tools designed to streamline workforce management for small and midsized businesses. These AI features, such as human-in-the-loop smart scheduling and agent-assisted time-off approvals, reflect Paychex’s push to bring enterprise-grade automation and transparency to everyday HR tasks. Next, we’ll examine how...

In early March 2026, Air Canada announced that the first of its updated Boeing 737 MAX 8 aircraft entered service with Air Canada Rouge, featuring retrofitted cabins with personal seatback entertainment, reclining seats, complimentary fast Wi‑Fi sponsored by Bell, and refreshed food and beverage offerings across its leisure and sun routes. This marks a wider fleet modernization push, as Air Canada transitions up to 45 Boeing 737 MAX aircraft to Rouge and upgrades mainline, regional, and...

Canfor Corporation reported fourth-quarter 2025 results showing sales of C$1,282.3 million, an operating loss of C$415.9 million and a net loss of C$390.5 million, driven by weak lumber and pulp markets, elevated US tariffs and a C$320.4 million asset impairment. Alongside these losses, Canfor moved ahead with its transformation plan, closing high-cost mills, shifting investment to the US South and Sweden, and securing shareholder approval to acquire the remaining stake in Canfor Pulp...

AUB Group (ASX:AUB) has just completed a follow on equity offering of A$10.57m at A$23.62 per share, adding 447,640 new ordinary shares and coinciding with fresh share purchases from the CEO and directors. See our latest analysis for AUB Group. The recent equity raise comes after a softer run for the shares, with a 30 day share price return of a 13.52% decline and a 90 day share price return of a 23.18% decline. The 5 year total shareholder return of 57.98% contrasts with weaker 1 and 3 year...

In early March 2026, Bank of America Corporation issued a series of new senior unsecured notes across multiple maturities while simultaneously moving to redeem existing US dollar, euro, and yen senior notes ahead of their 2027 maturities, reshaping its funding profile. This combination of fresh fixed‑income offerings and early redemptions highlights how the bank is actively managing its liability mix and interest costs against a backdrop of sector risks and geopolitical uncertainty. We’ll...

Northland Power (TSX:NPI) is back in focus after reporting fourth quarter 2025 results, with sales of CA$722.84 million, revenue of CA$725.26 million, and net income of CA$289.82 million. See our latest analysis for Northland Power. At a share price of CA$21.25, Northland Power has delivered a 24.12% 90 day share price return and a 14.38% 1 year total shareholder return, hinting at improving momentum after weaker multi year total returns. If this earnings update has you looking beyond a...

Why Quest Diagnostics Stock Is on Investors’ Radar Quest Diagnostics (DGX) is back in focus after recent trading, with the share price last closing at $199.21. Investors are weighing that level against the company’s earnings profile, cash generation, and overall business stability. See our latest analysis for Quest Diagnostics. While the 1-day share price return of 2.34% and 7-day share price return of 5.99% have cooled sentiment a bit, the 30-day and year-to-date share price returns of 4.46%...

In late February and early March 2026, analysts including Citi, Raymond James, and Barclays turned more cautious on American Homes 4 Rent, citing softer rental demand, elevated new supply, and rising concessions across single-family and multifamily markets. At Citi’s Miami Global Property CEO Conference 2026, American Homes 4 Rent outlined its response with a new US$500 million share repurchase authorization and plans to develop about 1,900 homes in 2026 while closely tracking legislative...

Earnings, dividend and buyback: what changed at Glanbia (ISE:GL9) Glanbia (ISE:GL9) has drawn fresh attention after reporting full year earnings, recommending a higher annual dividend and launching a share buyback program of up to €100 million. See our latest analysis for Glanbia. The market reaction has been broadly positive, with a 90 day share price return of 16.87% and a year to date share price return of 19.61%. The 1 year total shareholder return of 76.82% points to strong momentum...

In early March 2026, Arcutis Biotherapeutics reported strong 2025 results with revenue of US$376.07 million, a swing to quarterly profitability, raised its 2026 net product revenue guidance to US$480 million–US$495 million, advanced its ARQ-234 atopic dermatitis program into a Phase 1a/1b trial, and elevated Mas Matsuda to executive vice president, chief legal officer, and corporate secretary. Together, these developments point to a company moving from pure development-stage biotech toward a...

Repligen (RGEN) has been under pressure after a weaker February jobs report hit healthcare stocks, even as the company recently reported quarterly and full year 2025 results that showed positive revenue and net income figures. See our latest analysis for Repligen. At a share price of US$119.99, Repligen has seen a 1 day share price return of 4.03% decline, a 30 day share price return of 15.61% decline, and a 1 year total shareholder return of 22.94% decline. This suggests momentum has been...

Stanmore Resources Limited recently reported full-year 2025 results showing revenue of US$1.89 billion, down from US$2.50 billion in 2024, and a net loss of US$47.2 million compared with prior-year net income of US$191.5 million. Despite swinging to a loss, the company lifted its fully franked ordinary dividend to US$0.089 per share, signalling confidence in cash generation supported by record saleable coal production of 14.0 Mt amid earlier weather disruptions. We’ll now examine how...

Graham Holdings Company recently reported its fourth-quarter and full-year 2025 results, with quarterly sales edging up to US$1,251.02 million while net income and earnings per share from continuing operations fell sharply year over year, alongside US$10.10 million of impairment charges on intangible and other long-lived assets. The company’s decision to maintain a regular quarterly dividend of US$1.88 per share, even as full-year net income dropped significantly, highlights a continued...

Lindsay (LNN) has rolled out two new road safety products, the Road Runner Truck Mounted Attenuator and the AlphaGuard channelizing device, giving investors fresh information on its infrastructure focused portfolio. See our latest analysis for Lindsay. The recent product launches come as Lindsay's 90 day share price return of 9.67% and year to date share price return of 6.97% contrast with a 1 year total shareholder return of 0.72% decline, suggesting shorter term momentum has picked up after...

CNO Financial Group recently expanded its retirement offerings through Bankers Life’s Enhanced Death Benefit Rider for its Guaranteed Lifetime Income Annuity products, while its survey of Americans aged 50 to 85 highlighted growing concerns about inflation, longevity risk, and potential Social Security changes. Together, the new rider and survey insights underline how middle-income retirees are increasingly focused on balancing guaranteed income with the ability to leave a financial legacy...

Quarterly earnings and dividend catch investors’ attention Smith & Wesson Brands (SWBI) recently reported third quarter results alongside a fresh dividend announcement. This gives investors new data on both operating performance and direct cash returns. For the quarter ended January 31, 2026, sales were US$135.71 million compared with US$115.89 million a year earlier, while net income was US$3.75 million versus US$2.10 million. See our latest analysis for Smith & Wesson Brands. The earnings...